Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib with Carboplatin and Etoposide in ED SCLC
NCT02289690Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of veliparib in small cell lung cancer (SCLC), sponsored by AbbVie Inc.. Started Oct 2014; status: completed.
02
Drugs
veliparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02289690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289690.